Research progress of neuromodulation in the treatment of Parkinson's disease

Parkinson's disease (PD) is a common degenerative neurological disorder, characterized by static tremor, bradykinesia, myotonia and postural abnormalities. Dopaminergic drugs are the main drugs in the treatment of PD, but long-term use will lead to drug efficacy loss, and even cause some advers...

Full description

Bibliographic Details
Main Authors: HU Canfang, ZHONG Chuanyu, CAO Li
Format: Article
Language:zho
Published: Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science) 2024-02-01
Series:Shanghai Jiaotong Daxue xuebao. Yixue ban
Subjects:
Online Access:https://xuebao.shsmu.edu.cn/CN/10.3969/j.issn.1674-8115.2024.02.012
_version_ 1797244957975642112
author HU Canfang
ZHONG Chuanyu
CAO Li
author_facet HU Canfang
ZHONG Chuanyu
CAO Li
author_sort HU Canfang
collection DOAJ
description Parkinson's disease (PD) is a common degenerative neurological disorder, characterized by static tremor, bradykinesia, myotonia and postural abnormalities. Dopaminergic drugs are the main drugs in the treatment of PD, but long-term use will lead to drug efficacy loss, and even cause some adverse reactions such as dyskinesia and "on-off" phenomenon. Neuromodulation is a kind of biomedical engineering technology that can stimulate or inhibit the activity of brain neurons and regulate the changes of neuroplasticity by means of electric energy, magnetic field, ultrasound and other methods, so as to achieve treatment and improvement of diseases. In the non-drug treatment of PD, neuromodulation, as a new therapeutic means, has shown good efficacy, and has the advantages of small adverse reactions and easy tolerance. Based on this, this article reviews the research progress of several common neuromodulation in PD, including deep brain stimulation, transcranial magnetic stimulation, transcranial direct current stimulation and transcranial focused ultrasound.
first_indexed 2024-04-24T19:19:16Z
format Article
id doaj.art-0bc50a8d62f049318fa045064a099ff4
institution Directory Open Access Journal
issn 1674-8115
language zho
last_indexed 2024-04-24T19:19:16Z
publishDate 2024-02-01
publisher Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science)
record_format Article
series Shanghai Jiaotong Daxue xuebao. Yixue ban
spelling doaj.art-0bc50a8d62f049318fa045064a099ff42024-03-26T03:15:46ZzhoEditorial Office of Journal of Shanghai Jiao Tong University (Medical Science)Shanghai Jiaotong Daxue xuebao. Yixue ban1674-81152024-02-0144225826310.3969/j.issn.1674-8115.2024.02.0121674-8115(2024)02-0258-06Research progress of neuromodulation in the treatment of Parkinson's diseaseHU Canfang0ZHONG Chuanyu1CAO Li2Department of Neurology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200233, ChinaDepartment of Ultrasound Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200233, ChinaDepartment of Neurology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200233, ChinaParkinson's disease (PD) is a common degenerative neurological disorder, characterized by static tremor, bradykinesia, myotonia and postural abnormalities. Dopaminergic drugs are the main drugs in the treatment of PD, but long-term use will lead to drug efficacy loss, and even cause some adverse reactions such as dyskinesia and "on-off" phenomenon. Neuromodulation is a kind of biomedical engineering technology that can stimulate or inhibit the activity of brain neurons and regulate the changes of neuroplasticity by means of electric energy, magnetic field, ultrasound and other methods, so as to achieve treatment and improvement of diseases. In the non-drug treatment of PD, neuromodulation, as a new therapeutic means, has shown good efficacy, and has the advantages of small adverse reactions and easy tolerance. Based on this, this article reviews the research progress of several common neuromodulation in PD, including deep brain stimulation, transcranial magnetic stimulation, transcranial direct current stimulation and transcranial focused ultrasound.https://xuebao.shsmu.edu.cn/CN/10.3969/j.issn.1674-8115.2024.02.012neuromodulationparkinson's disease (pd)deep brain stimulation (dbs)transcranial magnetic stimulation (tms)transcranial direct current stimulation (tdcs)transcranial focused ultrasound (tfus)
spellingShingle HU Canfang
ZHONG Chuanyu
CAO Li
Research progress of neuromodulation in the treatment of Parkinson's disease
Shanghai Jiaotong Daxue xuebao. Yixue ban
neuromodulation
parkinson's disease (pd)
deep brain stimulation (dbs)
transcranial magnetic stimulation (tms)
transcranial direct current stimulation (tdcs)
transcranial focused ultrasound (tfus)
title Research progress of neuromodulation in the treatment of Parkinson's disease
title_full Research progress of neuromodulation in the treatment of Parkinson's disease
title_fullStr Research progress of neuromodulation in the treatment of Parkinson's disease
title_full_unstemmed Research progress of neuromodulation in the treatment of Parkinson's disease
title_short Research progress of neuromodulation in the treatment of Parkinson's disease
title_sort research progress of neuromodulation in the treatment of parkinson s disease
topic neuromodulation
parkinson's disease (pd)
deep brain stimulation (dbs)
transcranial magnetic stimulation (tms)
transcranial direct current stimulation (tdcs)
transcranial focused ultrasound (tfus)
url https://xuebao.shsmu.edu.cn/CN/10.3969/j.issn.1674-8115.2024.02.012
work_keys_str_mv AT hucanfang researchprogressofneuromodulationinthetreatmentofparkinsonsdisease
AT zhongchuanyu researchprogressofneuromodulationinthetreatmentofparkinsonsdisease
AT caoli researchprogressofneuromodulationinthetreatmentofparkinsonsdisease